TerminatedNot Applicable

Sarcopenia and Related Factors in Coronavirus Disease 2019 (COVID-19) Following Intensive Care

Stopped: techincal reasons

Turkey (Türkiye)30 participantsStarted 2021-03-01

Plain-language summary

The primary aim of this study is to evaluate the patients who had pneumonia or severe acute respiratory distress syndrome (ARDS) due to COVID-19 in terms of sarcopenia and related factors following Intensive Care Unit (ICU). The patients who had COVID-19 infection in the ICU and the patients who admitted to the 'Physical Medicine and Rehabilitation' clinic for other reasons during the pandemic period will be compared in terms of sarcopenia.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with ARDS or severe pneumonia due to COVID-19 hospitalized in intensive care unit * \> 18 years old * Age and gender matched patients admitted to the 'Physical Medicine and Rehabilitation' clinic for control group Exclusion Criteria: * Other diseases that may cause sarcopenia (cancer, non-respiratory organ failure and heart, liver or kidney failure) * Neurological diseases that may cause sarcopenia (stroke, spinal cord injury, muscle diseases)

What they're measuring

Hand grip strength

Timeframe: 12 months

Trial details

NCT IDNCT05474157

SponsorKoç University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-01-01

View on ClinicalTrials.gov More Sarcopenia trials